Overexpression of SLC25A15 is involved in the proliferation of cutaneous melanoma and leads to poor prognosis

Oncogene-Driven Metabolic Alterations in Cancer

(2018) Hye-Young Min et al.   Biomolecules & Therapeutics

Targeting Glutamine Metabolism for Cancer Treatment

(2018) Yeon-Kyung Choi et al.   Biomolecules & Therapeutics

Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy

(2018) Soumaya Kouidhi et al.   Frontiers in Immunology

Elucidating the Metabolic Plasticity of Cancer: Mitochondrial Reprogramming and Hybrid Metabolic States

(2018) Dongya Jia et al.   Cells

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

(2017) Zefang Tang et al.   NUCLEIC ACIDS RESEARCH

Acquired Amino Acid Deficiencies: A Focus on Arginine and Glutamine

(2017) Claudia R. Morris et al.   NUTRITION IN CLINICAL PRACTICE

Current status and perspectives in immunotherapy for metastatic melanoma

(2017) Riccardo Marconcini et al.   Oncotarget

The Impact of Genomics in Understanding Human Melanoma Progression and Metastasis

(2017) Suping Ren et al.   Cancer Control

Arginine deiminase: recent advances in discovery, crystal structure, and protein engineering for improved properties as an anti-tumor drug

(2016) Rui-Zhi Han et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Arginine dependence of tumor cells: targeting a chink in cancer’s armor

(2016) M D Patil et al.   ONCOGENE

Targeting arginine metabolism pathway to treat arginine-dependent cancers

(2015) Fuming Qiu et al.   CANCER LETTERS

Pathogenic potential of SLC25A15 mutations assessed by transport assays and complementation of Saccharomyces cerevisiae ORT1 null mutant

(2015) Carlo M.T. Marobbio et al.   MOLECULAR GENETICS AND METABOLISM

Targeting argininosuccinate synthetase negative melanomas using combination of arginine degrading enzyme and cisplatin

(2015) Niramol Savaraj et al.   Oncotarget

Mitochondrial transporters of the SLC25 family and associated diseases: a review

(2014) Ferdinando Palmieri   JOURNAL OF INHERITED METABOLIC DISEASE

A novel mutation in the SLC25A15 gene in a Turkish patient with HHH syndrome: Functional analysis of the mutant protein

(2014) Nagehan Ersoy Tunalı et al.   MOLECULAR GENETICS AND METABOLISM

Arginine Deiminase Resistance in Melanoma Cells Is Associated with Metabolic Reprogramming, Glucose Dependence, and Glutamine Addiction

(2013) Yan Long et al.   MOLECULAR CANCER THERAPEUTICS

Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase

(2012) L G Feun et al.   BRITISH JOURNAL OF CANCER

The mitochondrial transporter family SLC25: Identification, properties and physiopathology

(2012) Ferdinando Palmieri   MOLECULAR ASPECTS OF MEDICINE

Metabolic reprogramming of the tumor

(2012) L M R Ferreira et al.   ONCOGENE

Cancer Cell Metabolism: One Hallmark, Many Faces

(2012) Jason R. Cantor et al.   Cancer Discovery

Functional Amino Acids in Growth, Reproduction, and Health

(2012) Guoyao Wu   Advances in Nutrition

SLC6A14 (ATB0,+) Protein, a Highly Concentrative and Broad Specific Amino Acid Transporter, Is a Novel and Effective Drug Target for Treatment of Estrogen Receptor-positive Breast Cancer

(2011) Senthil Karunakaran et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Arginine Deprivation, Autophagy, Apoptosis (AAA) for the Treatment of Melanoma

(2010) N. Savaraj et al.   CURRENT MOLECULAR MEDICINE

Arginine Deiminase as a Novel Therapy for Prostate Cancer Induces Autophagy and Caspase-Independent Apoptosis

(2009) R. H. Kim et al.   CANCER RESEARCH